311383
氧化砷(III)
ACS reagent (primary standard)
别名:
三氧化二砷, 亚砷酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
As2O3
化学文摘社编号:
分子量:
197.84
NACRES:
NB.24
PubChem Substance ID:
UNSPSC Code:
12171602
EC Number:
215-481-4
MDL number:
eCl@ss:
38080102
Assay:
99.95-100.05%
Grade:
ACS reagent (primary standard)
Form:
powder
Solubility:
dilute HCl: insoluble ≤0.01%
InChI key
IKWTVSLWAPBBKU-UHFFFAOYSA-N
InChI
1S/As2O3/c3-1-5-2-4
SMILES string
O=[As]O[As]=O
grade
ACS reagent (primary standard)
vapor pressure
0 hPa ( 66 °C)
assay
99.95-100.05%
form
powder
reaction suitability
reagent type: catalyst
core: arsenic
ign. residue
≤0.02%
solubility
dilute HCl: insoluble ≤0.01%
anion traces
S2-: passes test (lim. ~0.001%), chloride (Cl-): ≤0.005%
cation traces
Fe: ≤5 ppm, Pb: ≤0.002%, Sb: ≤0.05%
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
氧化砷（III），也称为三氧化二砷，是一种可用作合成多种砷基化合物原料的两性氧化物。
Application
氧化砷（III）可用于：
- 在封闭体系中通过静态氟化法合成五氟化砷（AsF5）。
- 在醋酸锌、2-甲氧基乙醇和单乙醇胺中加入As2O3，通过溶胶-凝胶自旋涂覆法制备砷掺杂 ZnO 薄膜。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1A - Eye Dam. 1 - Skin Corr. 1B - STOT RE 1
target_organs
Respiratory system,Cardio-vascular system,Gastrointestinal tract
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
监管及禁止进口产品
此项目有
Xiao Liu et al.
Science China. Life sciences, 63(11), 1744-1754 (2020-05-10)
This study aimed to explore macrophage polarization in acute graft-versus-host disease after hematopoietic stem cell transplantation, and investigated if arsenic trioxide (ATO) could correct this imbalance. In the colon of GVHD mice, we found that the number of F4/80+iNOS+ cells
Yanfei Jia et al.
PloS one, 8(1), e54774-e54774 (2013-02-06)
Alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC), represented by the production of AFP, has a more aggressive behavior than common gastric cancer. The underlying mechanisms are not well understood. Arsenic trioxide (As(2)O(3)) is used clinically to treat acute promyelocytic leukemia(APL) and has
Yuhua Fan et al.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 31(1), 80-91 (2013-02-01)
Arsenic trioxide (As2O3) is a highly effective agent for treatment of acute promyelocytic leukemia (APL). However, consecutively administered As2O3 induces serious adverse cardiac effects, including long QT syndrome (LQTs) and even sudden cardiac death. Previous studies have shown that genistein
Liangchun Hao et al.
Journal of pediatric hematology/oncology, 35(2), e67-e70 (2013-02-16)
The aim of this study was to investigate the hepatotoxicity induced by arsenic trioxide (As2O3) at a therapeutic dose for pediatric acute promyelocytic leukemia (APL). A total of APL patients received As2O3 treatment by IV drip. Hepatotoxicity was monitored based
Ling-Huei Yih et al.
Toxicology and applied pharmacology, 267(3), 228-237 (2013-01-29)
Accumulated evidence has revealed a tight link between arsenic trioxide (ATO)-induced apoptosis and mitotic arrest in cancer cells. AKT, a serine/threonine kinase frequently over-activated in diverse tumors, plays critical roles in stimulating cell cycle progression, abrogating cell cycle checkpoints, suppressing
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持